SCIENTIFIC REPORTS, ISSN 2045-2322, 07/2019, Volume 9, Issue 1, pp. 11098 - 11
We report a simple surface functionalization of glutathione-capped gold nanoclusters by hydrophobic ion pairing with alkylamine followed by a complete phase...
TRANSFORMATION | POLYMERIC NANOPARTICLES | METAL NANOCLUSTERS | TEMPERATURE | PHASE-TRANSFER | STABILITY | MULTIDISCIPLINARY SCIENCES | NANOCRYSTALS | COMPLEXES | EMISSION | QUANTUM DOTS | Encapsulation | Gold | Photons | Hydrophobicity | Poly(lactide-co-glycolide) | Polylactide-co-glycolide | Glutathione
TRANSFORMATION | POLYMERIC NANOPARTICLES | METAL NANOCLUSTERS | TEMPERATURE | PHASE-TRANSFER | STABILITY | MULTIDISCIPLINARY SCIENCES | NANOCRYSTALS | COMPLEXES | EMISSION | QUANTUM DOTS | Encapsulation | Gold | Photons | Hydrophobicity | Poly(lactide-co-glycolide) | Polylactide-co-glycolide | Glutathione
Journal Article
Interface Focus, ISSN 2042-8898, Volume 2, Issue 3, pp. 366 - 377
Porous scaffolds fabricated from biocompatible and biodegradable polymers play vital roles in tissue engineering and regenerative medicine. Among various...
Biodegradation | Mechanical properties | Porous scaffolds | Tissue engineering | Poly(lactide-co-glycolide) (PLGA) | tissue engineering | BLOCK-COPOLYMERS | VIVO DEGRADATION | porous scaffolds | POLY(D,L-LACTIDE-CO-GLYCOLIDE) SCAFFOLDS | SURFACE MODIFICATION | biodegradation | MECHANICAL-PROPERTIES | mechanical properties | MESENCHYMAL STEM-CELLS | BONE-FORMATION | IN-VITRO DEGRADATION | poly(lactide-co-glycolide) (PLGA) | BIOLOGY | POLY(L-LACTIC ACID) | POLYMERIC SCAFFOLDS | 1004 | Review
Biodegradation | Mechanical properties | Porous scaffolds | Tissue engineering | Poly(lactide-co-glycolide) (PLGA) | tissue engineering | BLOCK-COPOLYMERS | VIVO DEGRADATION | porous scaffolds | POLY(D,L-LACTIDE-CO-GLYCOLIDE) SCAFFOLDS | SURFACE MODIFICATION | biodegradation | MECHANICAL-PROPERTIES | mechanical properties | MESENCHYMAL STEM-CELLS | BONE-FORMATION | IN-VITRO DEGRADATION | poly(lactide-co-glycolide) (PLGA) | BIOLOGY | POLY(L-LACTIC ACID) | POLYMERIC SCAFFOLDS | 1004 | Review
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 12/2003, Volume 52, Issue 6, pp. 981 - 986
Objectives: To improve the bioavailability of antitubercular drugs (ATDs) as well as to assess the feasibility of administering ATDs via the respiratory route,...
Nanoparticles | Antitubercular drugs | Nebulization | Tuberculosis | Poly(DL-lactide-co-glycolide) | INFECTIOUS DISEASES | THERAPEUTIC EFFICACY | COMPLEX | ACID | MICROSPHERES | tuberculosis | RIFAMPIN | MICROBIOLOGY | MICROPARTICLES | poly(DL-lactide-co-glycolide) | nanoparticles | PHARMACOLOGY & PHARMACY | MICE | antitubercular drugs | nebulization | Lung - microbiology | Injections, Intravenous | Area Under Curve | Half-Life | Biological Availability | Male | Tuberculosis - microbiology | Colony Count, Microbial | Mycobacterium tuberculosis - drug effects | Drug Carriers | Microspheres | Tuberculosis - drug therapy | Chemical Phenomena | Drug Compounding | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Lung - metabolism | Rifampin - administration & dosage | Chemical and Drug Induced Liver Injury - pathology | Polymers | Antibiotics, Antitubercular - administration & dosage | Antitubercular Agents - therapeutic use | Pyrazinamide - administration & dosage | Guinea Pigs | Lactic Acid | Polyglycolic Acid | Administration, Inhalation | Chemistry, Physical | Pyrazinamide - therapeutic use | Isoniazid - administration & dosage | Particle Size | Animals | Antibiotics, Antitubercular - therapeutic use | Aerosols | Antitubercular Agents - administration & dosage | Antitubercular Agents - toxicity | Drug Combinations
Nanoparticles | Antitubercular drugs | Nebulization | Tuberculosis | Poly(DL-lactide-co-glycolide) | INFECTIOUS DISEASES | THERAPEUTIC EFFICACY | COMPLEX | ACID | MICROSPHERES | tuberculosis | RIFAMPIN | MICROBIOLOGY | MICROPARTICLES | poly(DL-lactide-co-glycolide) | nanoparticles | PHARMACOLOGY & PHARMACY | MICE | antitubercular drugs | nebulization | Lung - microbiology | Injections, Intravenous | Area Under Curve | Half-Life | Biological Availability | Male | Tuberculosis - microbiology | Colony Count, Microbial | Mycobacterium tuberculosis - drug effects | Drug Carriers | Microspheres | Tuberculosis - drug therapy | Chemical Phenomena | Drug Compounding | Female | Isoniazid - therapeutic use | Rifampin - therapeutic use | Lung - metabolism | Rifampin - administration & dosage | Chemical and Drug Induced Liver Injury - pathology | Polymers | Antibiotics, Antitubercular - administration & dosage | Antitubercular Agents - therapeutic use | Pyrazinamide - administration & dosage | Guinea Pigs | Lactic Acid | Polyglycolic Acid | Administration, Inhalation | Chemistry, Physical | Pyrazinamide - therapeutic use | Isoniazid - administration & dosage | Particle Size | Animals | Antibiotics, Antitubercular - therapeutic use | Aerosols | Antitubercular Agents - administration & dosage | Antitubercular Agents - toxicity | Drug Combinations
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 2008, Volume 125, Issue 3, pp. 193 - 209
Biodegradable nano/microparticles of poly( -lactide- -glycolide) (PLGA) and PLGA-based polymers are widely explored as carriers for controlled delivery of...
Nanoparticles | Proteins | Targeted drug delivery | PLGA | Peptides | Microparticles | GENE DELIVERY | CELLS IN-VITRO | DRUG-DELIVERY | microparticles | targeted drug delivery | peptides | BIODEGRADABLE TRIBLOCK COPOLYMER | CHEMISTRY, MULTIDISCIPLINARY | OF-THE-ART | POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES | nanoparticles | POLYMERIC NANOPARTICLES | PLGA-PEG-PLGA | proteins | PHARMACOLOGY & PHARMACY | LOADED NANOPARTICLES | PROTEIN DELIVERY | Particle Size | Lactic Acid - chemistry | Drug Carriers - therapeutic use | Nanotechnology - methods | Polyglycolic Acid - chemistry | Pharmaceutical Preparations - chemistry | Polymers - chemistry | Molecular Structure | Drug Carriers - chemistry | Drug Delivery Systems | Drugs | Drug delivery systems | Vehicles
Nanoparticles | Proteins | Targeted drug delivery | PLGA | Peptides | Microparticles | GENE DELIVERY | CELLS IN-VITRO | DRUG-DELIVERY | microparticles | targeted drug delivery | peptides | BIODEGRADABLE TRIBLOCK COPOLYMER | CHEMISTRY, MULTIDISCIPLINARY | OF-THE-ART | POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES | nanoparticles | POLYMERIC NANOPARTICLES | PLGA-PEG-PLGA | proteins | PHARMACOLOGY & PHARMACY | LOADED NANOPARTICLES | PROTEIN DELIVERY | Particle Size | Lactic Acid - chemistry | Drug Carriers - therapeutic use | Nanotechnology - methods | Polyglycolic Acid - chemistry | Pharmaceutical Preparations - chemistry | Polymers - chemistry | Molecular Structure | Drug Carriers - chemistry | Drug Delivery Systems | Drugs | Drug delivery systems | Vehicles
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 11/2017, Volume 146, pp. 273 - 278
The complex nature and the manufacturing process of poly( -lactide- -glycolide) (PLGA), a key component of PLGA-based microspheres, have made the...
Size exclusion chromatography | Method validation | Poly(lactide-co-glycolide) | High-performance liquid chromatography | Quantitative 1H nuclear magnetic resonance | Leuprorelin acetate microsphere | H nuclear magnetic resonance | Quantitative
Size exclusion chromatography | Method validation | Poly(lactide-co-glycolide) | High-performance liquid chromatography | Quantitative 1H nuclear magnetic resonance | Leuprorelin acetate microsphere | H nuclear magnetic resonance | Quantitative
Journal Article
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 2010, Volume 74, Issue 2, pp. 157 - 163
Poly(lactide-co-glycolide) (PLGA) nanoparticles coated with poloxamer 188 (Pluronic F-68) or polysorbate 80 (Tween 80) enable an efficient brain delivery of...
Nanoparticles | Loperamide | Tail-flick test | Glioblastoma | Poloxamer 188 | Rats | Mice | Poly(lactide-co-glycolide) | Polysorbate 80 | Doxorubicin | Blood–brain barrier | Blood-brain barrier | BOUND DOXORUBICIN | TOLERANCE | BARRIER | MEDIATED TRANSPORT | HEALTHY RATS | CHEMOTHERAPY | POLY(BUTYL CYANOACRYLATE) NANOPARTICLES | PHARMACOLOGY & PHARMACY | ALBUMIN | Chemistry, Pharmaceutical - methods | Nanoparticles - chemistry | Polysorbates - chemistry | Rats, Wistar | Drug Carriers - administration & dosage | Male | Drug Carriers - chemistry | Pain Threshold - drug effects | Female | Polyglactin 910 - chemistry | Polyglactin 910 - pharmacology | Doxorubicin - administration & dosage | Poloxamer - chemistry | Surface-Active Agents | Loperamide - administration & dosage | Loperamide - pharmacology | Random Allocation | Mice, Inbred ICR | Brain - drug effects | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Nanoparticles - administration & dosage | Doxorubicin - pharmacology | Drugs | Drug delivery systems | Anthracyclines | Brain tumors | Vehicles | Analgesics | Surface active agents | Gliomas | Analysis | Testing equipment | Laxatives
Nanoparticles | Loperamide | Tail-flick test | Glioblastoma | Poloxamer 188 | Rats | Mice | Poly(lactide-co-glycolide) | Polysorbate 80 | Doxorubicin | Blood–brain barrier | Blood-brain barrier | BOUND DOXORUBICIN | TOLERANCE | BARRIER | MEDIATED TRANSPORT | HEALTHY RATS | CHEMOTHERAPY | POLY(BUTYL CYANOACRYLATE) NANOPARTICLES | PHARMACOLOGY & PHARMACY | ALBUMIN | Chemistry, Pharmaceutical - methods | Nanoparticles - chemistry | Polysorbates - chemistry | Rats, Wistar | Drug Carriers - administration & dosage | Male | Drug Carriers - chemistry | Pain Threshold - drug effects | Female | Polyglactin 910 - chemistry | Polyglactin 910 - pharmacology | Doxorubicin - administration & dosage | Poloxamer - chemistry | Surface-Active Agents | Loperamide - administration & dosage | Loperamide - pharmacology | Random Allocation | Mice, Inbred ICR | Brain - drug effects | Xenograft Model Antitumor Assays | Animals | Cell Line, Tumor | Nanoparticles - administration & dosage | Doxorubicin - pharmacology | Drugs | Drug delivery systems | Anthracyclines | Brain tumors | Vehicles | Analgesics | Surface active agents | Gliomas | Analysis | Testing equipment | Laxatives
Journal Article
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, ISSN 0731-7085, 11/2017, Volume 146, pp. 273 - 278
The complex nature and the manufacturing process of poly(DL-lactide-co-glycolide) (PLGA), a key component of PLGA-based microspheres, have made the...
Quantitative H-1 nuclear magnetic resonance | Size exclusion chromatography | NANOPARTICLES | CHEMISTRY, ANALYTICAL | Poly(lactide-co-glycolide) Leuprorelin acetate microsphere | Method validation | PHARMACOLOGY & PHARMACY | RELEASE | High-performance liquid chromatography | CHROMATOGRAPHY | POLY(LACTIDE-CO-GLYCOLIDE)
Quantitative H-1 nuclear magnetic resonance | Size exclusion chromatography | NANOPARTICLES | CHEMISTRY, ANALYTICAL | Poly(lactide-co-glycolide) Leuprorelin acetate microsphere | Method validation | PHARMACOLOGY & PHARMACY | RELEASE | High-performance liquid chromatography | CHROMATOGRAPHY | POLY(LACTIDE-CO-GLYCOLIDE)
Journal Article
8.
Full Text
Cell affinity for bFGF immobilized heparin-containing poly(lactide-co-glycolide) scaffolds
Biomaterials, ISSN 0142-9612, 2011, Volume 32, Issue 13, pp. 3404 - 3412
Abstract In order to effectively and uniformly immobilize basic fibroblast growth factor (bFGF) to thick PLGA scaffold, the heparin-conjugated PLGA (H-PLGA)...
Advanced Basic Science | Dentistry | Immobilization | Slow release | PLGA | Heparin | Scaffold | bFGF | BFGF | MATERIALS SCIENCE, BIOMATERIALS | FACTOR DELIVERY | BONE MORPHOGENETIC PROTEIN-2 | ENGINEERING, BIOMEDICAL | POLY(L-LACTIC-CO-GLYCOLIC ACID) | SIGNALING MOLECULES | FIBROBLAST-GROWTH-FACTOR | RELEASE | POROUS SCAFFOLDS | IN-VITRO | REPAIR | PLASMA TREATMENT | Lactic Acid - chemistry | Tissue Engineering - methods | Fibroblast Growth Factor 2 - chemistry | Polyglycolic Acid - pharmacology | Cell Adhesion - drug effects | Fibroblasts - ultrastructure | Tissue Scaffolds - chemistry | Animals | Fibroblasts - drug effects | Polyglycolic Acid - chemistry | Cell Proliferation - drug effects | Fibroblasts - cytology | Mice | Lactic Acid - pharmacology | 3T3 Cells | Heparin - chemistry
Advanced Basic Science | Dentistry | Immobilization | Slow release | PLGA | Heparin | Scaffold | bFGF | BFGF | MATERIALS SCIENCE, BIOMATERIALS | FACTOR DELIVERY | BONE MORPHOGENETIC PROTEIN-2 | ENGINEERING, BIOMEDICAL | POLY(L-LACTIC-CO-GLYCOLIC ACID) | SIGNALING MOLECULES | FIBROBLAST-GROWTH-FACTOR | RELEASE | POROUS SCAFFOLDS | IN-VITRO | REPAIR | PLASMA TREATMENT | Lactic Acid - chemistry | Tissue Engineering - methods | Fibroblast Growth Factor 2 - chemistry | Polyglycolic Acid - pharmacology | Cell Adhesion - drug effects | Fibroblasts - ultrastructure | Tissue Scaffolds - chemistry | Animals | Fibroblasts - drug effects | Polyglycolic Acid - chemistry | Cell Proliferation - drug effects | Fibroblasts - cytology | Mice | Lactic Acid - pharmacology | 3T3 Cells | Heparin - chemistry
Journal Article
INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE, ISSN 1452-3981, 10/2019, Volume 14, Issue 10, pp. 9825 - 9837
This manuscript presents the results of investigating the properties of composite materials having poly(lactide-co-glycolide) (PLGA) matrix filled with...
ELECTROCHEMISTRY | POLYMERS | ACID | biodegradable composite material | hardness | LIGNOCELLULOSE COMPOSITES | E-WASTE | FTIR | electrolytic copper powder | DEVICES | electrical conductivity | Poly(lactide-co-glycolide) | TRANSIENT | ELECTRONICS
ELECTROCHEMISTRY | POLYMERS | ACID | biodegradable composite material | hardness | LIGNOCELLULOSE COMPOSITES | E-WASTE | FTIR | electrolytic copper powder | DEVICES | electrical conductivity | Poly(lactide-co-glycolide) | TRANSIENT | ELECTRONICS
Journal Article
Biomaterials, ISSN 0142-9612, 2000, Volume 21, Issue 23, pp. 2475 - 2490
A considerable research has been conducted on drug delivery by biodegradable polymeric devices, following the entry of bioresorbable surgical sutures in the...
Bioresorbable | Poly(lactide- co-glycolide) (PLGA) | Biodegradable | Poly(lactide-co-glycolide) (PLGA) | biodegradable | MATERIALS SCIENCE, BIOMATERIALS | DELIVERY SYSTEMS | ENGINEERING, BIOMEDICAL | SOLVENT EVAPORATION METHOD | HORMONE-RELEASING HORMONE | WATER EMULSION TECHNIQUE | HUMAN GROWTH-HORMONE | DEPOT INJECTABLE MICROSPHERES | poly(lactide-co-glycolide) (PLGA) | bioresorbable | ACID) MICROSPHERES | DL-LACTIDE/GLYCOLIDE COPOLYMER | IN-VIVO EVALUATION | SUSTAINED-RELEASE | Biodegradation, Environmental | Microspheres | Lactic Acid - chemistry | Polylactic Acid-Polyglycolic Acid Copolymer | Biocompatible Materials - chemistry | Polyglycolic Acid - chemistry | Polymers - chemistry | Drug Delivery Systems
Bioresorbable | Poly(lactide- co-glycolide) (PLGA) | Biodegradable | Poly(lactide-co-glycolide) (PLGA) | biodegradable | MATERIALS SCIENCE, BIOMATERIALS | DELIVERY SYSTEMS | ENGINEERING, BIOMEDICAL | SOLVENT EVAPORATION METHOD | HORMONE-RELEASING HORMONE | WATER EMULSION TECHNIQUE | HUMAN GROWTH-HORMONE | DEPOT INJECTABLE MICROSPHERES | poly(lactide-co-glycolide) (PLGA) | bioresorbable | ACID) MICROSPHERES | DL-LACTIDE/GLYCOLIDE COPOLYMER | IN-VIVO EVALUATION | SUSTAINED-RELEASE | Biodegradation, Environmental | Microspheres | Lactic Acid - chemistry | Polylactic Acid-Polyglycolic Acid Copolymer | Biocompatible Materials - chemistry | Polyglycolic Acid - chemistry | Polymers - chemistry | Drug Delivery Systems
Journal Article
Biomaterials, ISSN 0142-9612, 2013, Volume 35, Issue 1, pp. 550 - 566
Abstract To develop biodegradable docetaxel-loaded self-assembled nanoparticles of poly ( d , l -lactide-co-glycolide)/hyaluronic acid block copolymers were...
Advanced Basic Science | Dentistry | Poly (d,l-lactide-co-glycolide) | Breast cancer | Self-assembled nanoparticles | Hyaluronic acid | CD44 | Docetaxel | CELLS | MATERIALS SCIENCE, BIOMATERIALS | MOLECULAR-WEIGHT | GENE DELIVERY | DRUG-DELIVERY | ENGINEERING, BIOMEDICAL | DOXORUBICIN | MICELLES | Poly (D,L-lactide-co-glycolide) | HYALURONIC-ACID | CELLULAR UPTAKE | PACLITAXEL | CYTOTOXICITY | Breast Neoplasms - immunology | Humans | Molecular Sequence Data | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Drug Carriers | Nanoparticles | Taxoids - therapeutic use | Flow Cytometry | Female | Lactic Acid - administration & dosage | Polyglycolic Acid - administration & dosage | Carbohydrate Sequence | Hyaluronic Acid - administration & dosage | Lactic Acid - chemistry | Hyaluronic Acid - chemistry | Rats | Breast Neoplasms - drug therapy | Rats, Sprague-Dawley | Taxoids - administration & dosage | Animals | Breast Neoplasms - pathology | Polyglycolic Acid - chemistry | Cell Line, Tumor | Biocompatible Materials | Hyaluronan Receptors - immunology | Mice | Mice, Inbred BALB C | Antimitotic agents | Chemotherapy | Drugstores | Antineoplastic agents | Block copolymers | Cancer | Index Medicus
Advanced Basic Science | Dentistry | Poly (d,l-lactide-co-glycolide) | Breast cancer | Self-assembled nanoparticles | Hyaluronic acid | CD44 | Docetaxel | CELLS | MATERIALS SCIENCE, BIOMATERIALS | MOLECULAR-WEIGHT | GENE DELIVERY | DRUG-DELIVERY | ENGINEERING, BIOMEDICAL | DOXORUBICIN | MICELLES | Poly (D,L-lactide-co-glycolide) | HYALURONIC-ACID | CELLULAR UPTAKE | PACLITAXEL | CYTOTOXICITY | Breast Neoplasms - immunology | Humans | Molecular Sequence Data | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Drug Carriers | Nanoparticles | Taxoids - therapeutic use | Flow Cytometry | Female | Lactic Acid - administration & dosage | Polyglycolic Acid - administration & dosage | Carbohydrate Sequence | Hyaluronic Acid - administration & dosage | Lactic Acid - chemistry | Hyaluronic Acid - chemistry | Rats | Breast Neoplasms - drug therapy | Rats, Sprague-Dawley | Taxoids - administration & dosage | Animals | Breast Neoplasms - pathology | Polyglycolic Acid - chemistry | Cell Line, Tumor | Biocompatible Materials | Hyaluronan Receptors - immunology | Mice | Mice, Inbred BALB C | Antimitotic agents | Chemotherapy | Drugstores | Antineoplastic agents | Block copolymers | Cancer | Index Medicus
Journal Article
Journal of nanoscience and nanotechnology, ISSN 1533-4880, 07/2018, Volume 18, Issue 7, pp. 4478 - 4486
The biodegradable polymer, poly(lactide-co-glycolide) is a popular polymer of choice in many nanotherapeutic studies. Herein, we report on the synthesis and...
TARGET | Gold | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | MATERIALS SCIENCE, MULTIDISCIPLINARY | Transgene Expression | RECEPTOR | NANOSCIENCE & NANOTECHNOLOGY | TUMORS | CHEMISTRY, MULTIDISCIPLINARY | Folate | Nanoparticles | THERAPY | COUPLED FOLATE TRANSPORTER | LIPOPLEXES | Poly(lactide-co-glycolide) | Biological properties | Biotechnology | Infrared reflection | Particle size | Fourier transforms | Toxicity | Biodegradability | Cytotoxicity | Cobalt | Folic acid | Vitamin B | Nuclease | Polymers | Plasmid DNA | Physiochemistry | Protective coatings | Deoxyribonucleic acid--DNA | Binding | Breast cancer | Zeta potential | Breast | Chitosan | Gene therapy | Viability | Cancer
TARGET | Gold | PHYSICS, CONDENSED MATTER | PHYSICS, APPLIED | MATERIALS SCIENCE, MULTIDISCIPLINARY | Transgene Expression | RECEPTOR | NANOSCIENCE & NANOTECHNOLOGY | TUMORS | CHEMISTRY, MULTIDISCIPLINARY | Folate | Nanoparticles | THERAPY | COUPLED FOLATE TRANSPORTER | LIPOPLEXES | Poly(lactide-co-glycolide) | Biological properties | Biotechnology | Infrared reflection | Particle size | Fourier transforms | Toxicity | Biodegradability | Cytotoxicity | Cobalt | Folic acid | Vitamin B | Nuclease | Polymers | Plasmid DNA | Physiochemistry | Protective coatings | Deoxyribonucleic acid--DNA | Binding | Breast cancer | Zeta potential | Breast | Chitosan | Gene therapy | Viability | Cancer
Journal Article
SMALL, ISSN 1613-6810, 05/2008, Volume 4, Issue 5, pp. 662 - 669
Poly (lactide-co-glycolide) (PLG), a biocompatible and biodegradable polymer, is dramatically toughened by adding small amounts of surface modified clay...
PHYSICS, CONDENSED MATTER | poly(lactide-co-glycolide) | PHYSICS, APPLIED | PARTICLES | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | EMULSION POLYMERIZATION | NANOSCIENCE & NANOTECHNOLOGY | nanocomposites | BLENDS | CHEMISTRY, MULTIDISCIPLINARY | mechanical properties | biodegradable materials | relaxation modes | NANOCLAY | LAYERED SILICATE NANOCOMPOSITES | MORPHOLOGY
PHYSICS, CONDENSED MATTER | poly(lactide-co-glycolide) | PHYSICS, APPLIED | PARTICLES | MATERIALS SCIENCE, MULTIDISCIPLINARY | CHEMISTRY, PHYSICAL | EMULSION POLYMERIZATION | NANOSCIENCE & NANOTECHNOLOGY | nanocomposites | BLENDS | CHEMISTRY, MULTIDISCIPLINARY | mechanical properties | biodegradable materials | relaxation modes | NANOCLAY | LAYERED SILICATE NANOCOMPOSITES | MORPHOLOGY
Journal Article
AQUACULTURE, ISSN 0044-8486, 10/2019, Volume 512, p. 734290
Photobacterium damselae subsp. piscicida (PDP), the causative agent of fish pasteurellosis, has become a serious threat leading to high mortalities in...
Amidated pleurocidin (PLE(am)) | IMMUNITY | PROTEIN | MICROSPHERES | EFFICACY | DELIVERY-SYSTEMS | Photobacterium damselae subsp. piscicida (PDP) | ANTIMICROBIAL PEPTIDES | Poly (lactide-co-glycolide) (PLG) | PLG-PLE(am) microparticles | IN-VITRO | FISHERIES | MARINE & FRESHWATER BIOLOGY | Pleurocidin (PLE) | EXPRESSION
Amidated pleurocidin (PLE(am)) | IMMUNITY | PROTEIN | MICROSPHERES | EFFICACY | DELIVERY-SYSTEMS | Photobacterium damselae subsp. piscicida (PDP) | ANTIMICROBIAL PEPTIDES | Poly (lactide-co-glycolide) (PLG) | PLG-PLE(am) microparticles | IN-VITRO | FISHERIES | MARINE & FRESHWATER BIOLOGY | Pleurocidin (PLE) | EXPRESSION
Journal Article
Nanomedicine: Nanotechnology, Biology, and Medicine, ISSN 1549-9634, 2007, Volume 3, Issue 2, pp. 161 - 167
Abstract Biodegradable polymers such as poly lactide-co-glycolides (PLGA) have been considered for the preparation of nanoparticles (NPs). In this study,...
Internal Medicine | Nanoparticles | Antibacterial activity | Antimicrobial delivery | Rifampicin | Poly lactide-co-glycolide | antibacterial activity | MEDICINE, RESEARCH & EXPERIMENTAL | rifampicin | MICROSPHERES | TUBERCULOSIS | NANOSCIENCE & NANOTECHNOLOGY | RELEASE | MICROPARTICLES | FORMULATION | poly lactide-co-glycolide | DELIVERY | nanoparticles | NANOSPHERES | antimicrobial delivery | POLY(D,L-LACTIC ACID) | VARIABLES | Cell Survival - drug effects | Lactic Acid - chemistry | Nanoparticles - chemistry | Rifampin - chemistry | Bacteria - drug effects | Nanoparticles - ultrastructure | Coated Materials, Biocompatible - chemistry | Materials Testing | Drug Carriers - chemistry | Anti-Bacterial Agents - chemistry | Polyglycolic Acid - chemistry | Bacteria - cytology | Polymers - chemistry | Rifampin - administration & dosage | Anti-Bacterial Agents - administration & dosage | Antibiotics | Analysis | Nanotechnology
Internal Medicine | Nanoparticles | Antibacterial activity | Antimicrobial delivery | Rifampicin | Poly lactide-co-glycolide | antibacterial activity | MEDICINE, RESEARCH & EXPERIMENTAL | rifampicin | MICROSPHERES | TUBERCULOSIS | NANOSCIENCE & NANOTECHNOLOGY | RELEASE | MICROPARTICLES | FORMULATION | poly lactide-co-glycolide | DELIVERY | nanoparticles | NANOSPHERES | antimicrobial delivery | POLY(D,L-LACTIC ACID) | VARIABLES | Cell Survival - drug effects | Lactic Acid - chemistry | Nanoparticles - chemistry | Rifampin - chemistry | Bacteria - drug effects | Nanoparticles - ultrastructure | Coated Materials, Biocompatible - chemistry | Materials Testing | Drug Carriers - chemistry | Anti-Bacterial Agents - chemistry | Polyglycolic Acid - chemistry | Bacteria - cytology | Polymers - chemistry | Rifampin - administration & dosage | Anti-Bacterial Agents - administration & dosage | Antibiotics | Analysis | Nanotechnology
Journal Article